Assignee
TELIGENE LTD
CN·6 granted patents·2 pending applications·1 citations·filing 2012–2022
Top patents by PatentIndex Score
8 records- 0172US10159663B2Substituted macrocycles useful as kinases inhibitors and methods of use thereofTELIGENE LTD·Filed 2015·Granted Dec 25, 2018·1 cites·7 claims
- 0265US12338251B2Substituted macrocycles useful as kinase inhibitorsTELIGENE LTD·Filed 2022·Granted Jun 24, 2025·0 cites·20 claims
- 0358US11034656B2Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereofTELIGENE LTD·Filed 2018·Granted Jun 15, 2021·0 cites·20 claims
- 0448US9388170B2Substituted aminoquinazolines useful as kinases inhibitorsTELIGENE LTD·Filed 2013·Granted Jul 12, 2016·0 cites·9 claims
- 0548US2014350050A1Pyridine compounds as inhibitors of kinaseTELIGENE LTD·Filed 2012·Application pending·0 cites
- 0644US11344553B2Substituted pyrazolopyrimidines useful as kinases inhibitorsTELIGENE LTD·Filed 2018·Granted May 31, 2022·0 cites·18 claims
- 0743US9388160B2Quinazoline derivatives as kinases inhibitors and methods of use thereofTELIGENE LTD·Filed 2012·Granted Jul 12, 2016·0 cites·4 claims
- 0834US2018134683A1Heterocylcic compounds as idh2 inhibitorsTELIGENE LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TELIGENE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →